C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways

Abstract Objective Abnormal complement activation is associated with periodontitis. W54011 is a novel non-peptide C5aR antagonist (C5aRA) that exhibits favorable anti-inflammatory effects in various inflammatory models. However, whether W54011 inhibits periodontitis has not yet been fully elucidated. To address this, we have investigated the probable anti-inflammatory mechanism of W54011 in LPS-treated inflammation in human gingival fibroblasts (HGFs). Methodology HGFs were isolated from healthy gingival tissue samples using the tissue block method and were identified with immunofluorescence staining. The CCK8 assay and reverse transcription-PCR (RT-PCR) were used to select the optimal induction conditions for Lipopolysaccharide (LPS) and C5aRA (according to supplementary data S1, S2 and S3). The levels of inflammatory cytokines, C5aR, and the activation of NF-κB/MAPK signaling pathways were determined by RT-quantitative PCR (RT-qPCR) and Western blotting. Results Immunofluorescence results showed that vimentin and FSP-1 were positive in HGFs and Keratin was negative in HGFs. Immunofluorescence staining demonstrated that C5aRA inhibited LPS-stimulated nuclear translocation of p-p65. RT-qPCR and Western blotting showed that C5aRA reduced the expression of IL-1β, IL-6, TNF-α, C5aR, p-p65, p-IκBα, p-JNK, p-c-JUN, and TLR4 in LPS-induced HGFs. Conclusion These findings suggested that C5aRA attenuated the release of inflammatory cytokines in LPS-induced HGFs by blocking the activation of the NF-κB and MAPK signaling pathways.

Yan CHEN 1,2 # Yang LIU 3 Since it destroys the tissue surrounding the teeth, it may cause tooth loss if untreated.Periodontitis is regarded as the second most common dental disease worldwide, affecting more than 50% of the world's population. 1 The presence of bacteria is the primary etiological factor for periodontal diseases, but the susceptibility of the host is another important factor to consider, as their immune response is closely related to pathogen clearance.If the immune response in the host is too strong, the pathogen may be cleared, but this will cost excessive inflammatory damage to the host tissue. 2 A successful host immune response, thus, generally depends on the balance of pro-and anti-inflammatory cytokines, which are carefully adjusted to eliminate the pathogen while limiting host damage.A previous study showed that the occurrence of periodontitis is closely related to the activation of the complement system.The treatment chosen for periodontitis needs to determine the precise complement-associated signaling pathways with protective effects.The complement pathway with defensive functions can play a protective role and achieve the purpose of effective immunity. 3When the complement system is activated, anaphylatoxins are released, including complement components 3a (C3a), 4a (C4a), and 5a (C5a).Among them, C5a reported the most powerful effect, being 2500 and 20 times as potent as C4a and C3a, respectively.C5a is a glycoprotein composed of 74 amino acids, and it functions by binding to C5aR on the cell membranes of target cells. 4C5a can then chemotactic neutrophils and macrophages, promote inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β), and promote T-cell proliferation and B-cell production of antibodies to enhance the damaging effects of the inflammation. 5,6popolysaccharide (LPS), also known as endotoxin, is an essential component of the outer membrane of gram-negative bacteria.LPS can cause inflammation in various organs and tissues throughout the body, including periodontal tissue.8][9] In the early identification of a pathogen, innate immune responses are activated by Toll-like receptors (TLRs), which can sense specific molecular patterns. 10Toll-like receptor 4 (TLR4), as a transmembrane protein and member of the Toll-like receptor family, is activated by LPS.
The downstream signaling then cascades through the myd88-dependent pathway to initiate multiple signaling pathways, such as the mitogen-activated protein kinase (MAPK) and nuclear factor-κB (NF-κB) signaling pathways.This process induces the activation of downstream transcription factors such as NF-κB and activator protein-1 (AP-1) and the production of various pro-inflammatory factors, including IL-6, IL-1β, and TNF-α. 11Despite its protective role, complement stimulated by LPS may cause or exacerbate infection including periodontitis when excessively activated or deregulated. 3This process may not only directly trigger the cascade reaction of the C5a-c5aR axis, but also crosstalk and regulate other host pathways, disrupting the balance of immune and inflammatory responses in periodontal tissue, consequently aggravating the destruction of connective tissue in it, which may lead to tooth loosening and missing. 12Current treatment methods for periodontal disease include both surgical and non-surgical approaches, although the long-term use of antibiotics can lead to an increase in resistant strains of resident bacteria.Thus, it is crucial that we develop safe and effective drugs for the treatment of

Isolation and culture of human gingival fibroblasts
Human gingival fibroblasts (HGFs) were isolated from gingival tissues taken from the area around impacted third molars or periodontal healthy premolars, which were primarily extracted by orthodontics with the consent of the patient and/or guardian.The selected donors were aged from 18 to 25, in good health, without systemic diseases, without genetic diseases, non-smokers, antibiotic-free in the past six months, and had good oral hygiene.The malefemale ratio was 1:1.This study was approved by the Institutional Ethics Committee of the Second Affiliated Hospital of Harbin Medical University.A total of 30 gum samples were collected for three consecutive days.
Considering that the cells of different patients may have differences, the samples obtained were mixed and extracted every day.Contamination occurred in six samples on the second day, and cells with similar morphology were obtained within 14 days from 24 tissue samples without contamination.Specific steps are as follows: the freshly excised gingival tissue was immediately placed in pre-cooled Dulbecco's Modified Eagle Medium (DMEM)-F12 (containing 1% penicillin and 1% streptomycin) (HyClone; GE Healthcare Life Sciences) and soaked for later use.The collected gingival tissues were stored in a refrigerator at 4 °C and experimentally extracted within 4 h of sampling.
They were cut into approximately 1.0 mm 3 pieces (1mL of DMEM-F12 medium on the tissue block when cutting was added), and a dental probe was used to evenly spread the tissue block on the wall of a 25 cm 2 sterile culture flask.The flask was turned over and incubated at 37 °C, 5% CO 2 for 1 h.After that, 2 mL of DMEM-F12 supplemented with 10% fetal bovine serum (Biological Industries), penicillin (100 U/mL), and streptomycin (100 μg/mL) was added in the flip-back flask at 37 °C with 5% CO 2 .On the fourth day of culture, 2 mL DMEM-F12 medium was supplemented.The medium was changed for the first time on day seven, using a pipette to gently aspirate the culture medium, to ensure that the pipette did not contact the tissue.
During this process, the tissue block was attached to the bottom of the culture bottle.The medium was then replaced every second day.As the adherent cells increased, the tissue pieces floating alongside them also had to be removed when changing the medium.
Primary cells were passaged when they were 80-90% confluent.Cell adherence was observed using an inverted microscope.

Purification of human gingival fibroblasts
All primary cells were cultured for no longer than 14 days to avoid cell senescence.Therefore, when the earliest extracted sample was cultured for 14 days, we digested all primary cells (observe that the number of cells in the culture flask with the least amount of cells also reached 75% confluent) according to the differential digestion method, then mixed resuspended cells for passage.Specific steps are as follows: enzymatic digestion was used to purify the HGFs.Under the action of trypsin at 25 °C for 3-4 minutes, fibroblasts peeled off first, while epithelial cells required more time to digest before peeling off.The supernatant was carefully collected and then centrifuged at 1,000 rpm for 5 min (Cell count approximately 3.6×10 7 ).The resuspended cell pellet was transferred to a flask, which was then filled up to 4 mL with the DMEM-F12 medium.After the second-generation cells are congested, some will be used for subsequent research such as identification and induction, and some will be frozen for future use.

Identification of gingival fibroblasts using immunofluorescence
The second-passage cells were plated in 24-well plates at a density of 8000 cells per well.When the cells reached 50-70% confluence, they were washed twice with PBS and fixed with 4% paraformaldehyde

NF-κB activation-nuclear transport assay
The NF-κB Activation-Nuclear Transport Assay Kit (SN368, Beyotime Biotechnology Limited Company, Shanghai, China) was used to detect p-p65, under the guidance of the manufacturer's instructions.Fourth HGFs were cultured in a 24-well plate containing cell slides (8000 cells/well).After the cells securely adhered, they were cultured in serum-free DMEM-F12 for 24 h and were then divided into three groups, as follows: i) 1 μg/mL LPS (48 h) + C5aRA (48 h); ii) serum-free DMEM-F12 alone for 4 days (negative control group); and iii) 1 μg/mL LPS (48 h).Cells in each group were rinsed with PBS for 3 × 5 min, fixed with a fixative for 10 min, then washed for 3 × 5 min.
An immunostaining blocking solution was used to block cells at 25 °C for 1 h.The p-p65 antibody was incubated overnight at 4°C.The secondary antibody (anti-rabbit Cy3) was then added and incubated at 25 °C for 1 h.The cells were stained with a nucleus staining agent (DAPI) at 25 °C for approximately 5 min.

Treatment groups and culture conditions
According to supplementary data S1, S2 and S3 the cultured cells were divided into four groups, as follows: i) 1 μg/mL LPS for 48h, then add 1 μg/mL C5aRA (W54011, HY-16992A; MedChemExpress, USA) for another 48h; ii) serum-free culture medium (96 h) as the control group; iii) serum-free medium for 48 h at first, then add 1 μg/mL LPS for 48 h; and iv) serum-free medium for 48 h at first, then add 1 μg/mL C5aRA for 48h.All groups were starved for 24 hours with the serum-free medium at first, and then added LPS or C5aRA according to the grouping described above.

ELISA assay
Cells were divided into four groups as described before, and the cell supernatant was extracted.
Following the manufacturer's protocol, the activation of C5a in cell supernatant was performed using a C5a enzyme immunoassay kit (Abcam, Cambridge, UK), as previously described. 21Finally, the absorbance at 450 nm was measured with a microplate reader.

Real-Time Quantitative PCR analysis
The fourth generation cells were split into four 100mm 2 plates.When the cell fusion reached 80-90%,

Western blotting analysis
Cells were grown to 80-90% confluence in a 100 mm 2 dish.The cells were added with RIPA lysis buffer supplemented with 1% PMSF (Beyotime, China) to extract total proteins.Cells were ultrasonically shaken for 1 min (2 s shaking, 1 s stop, ampl 40%) and then centrifuged at 13,300 × g for 15 min at 4 °C.The All values of this study are expressed as the mean ± SEM.P < 0.05 was considered statistically significant.

Isolation and culture of human gingival fibroblasts
We successfully isolated HGFs from 24 test samples using the tissue block adherence method.On the second day, we observed the flat polygonal cells isolated from gingival tissue blocks and tightly packed them into clone-like clumps (Figure 2A).After four days of culture, a small number of spindle-shaped or short-fusiform adherent cells could be observed from other tissue blocks (Figure 2B).We observed a significant increase in the number of spindle-shaped or short-fusiform adherent cells on day seven of the culture (Figure 2C).On day 10, the number of adherent cells increased significantly, and two obvious cell shapes were observed: flat polygonal and long spindles (Figure 2D).On day 14, almost no clear boundary between the two cell types was observed.
At this time, the proliferating cell clusters were close to each other, and cells reaching 80%-90% confluence could be passaged (Figure 2E).Cells were digested with trypsin for 3-4 minutes at 25 °C.At this point, almost all fibroblast-like cells curled up and detached  from the culture flask.However, polygonal cells retained their original morphology.After passage, the morphology and size of the fibroblast-like cells were relatively uniform and typical for their cell type (Figure 2F).The cells proliferated rapidly and were passaged every 3-4 days.

Identification of the source of human gingival fibroblasts
Fluorescence microscopy showed that secondgeneration cells had a single long spindle shape arranged in parallel, and the volume of the passaged cells was slightly larger than that of the primary cells  C5aRA affected the expression of C5a, C5aR, and inflammatory factors in HGFs treated by LPS ELISA results showed that compared with the control group, the concentration of C5a in the LPS group was significantly increased and that there was no significant difference between the LPS + C5aRA group and the LPS group.The expression of C5a in the C5aRA group alone was not significantly different from that in the control group (Figure 4).
The trends in the results of RT-qPCR and Western blotting analysis were the same (Figure 5).They showed that the mRNA and protein expression levels for inflammatory factors IL-1β, IL-6, TNF-α , and C5aR in the LPS group expressed a significantly higher level of the inflammatory factor than the control group.Then, the LPS + C5aRA group significantly downregulated the mRNA and protein expression levels of IL-1β, IL-6, TNF-α , and C5aR.This indicates that C5aRA significantly inhibited LPS-induced inflammation in human gingival fibroblasts.Furthermore, compared to the LPS + C5aRA group, the C5aRA alone group showed upregulated mRNA and protein expression levels for IL-1β, IL-6, TNF-α , and C5aR.
C5aRA affected TLR4/NF-κB signaling pathway after being treated by LPS Western blotting and RT-qPCR analyses showed that the expression levels of TLR4, p-p65, and p-IκBα in the LPS group were significantly higher than those in the control group and that the C5aRA treatment could further increase the expression levels of TLR4, p-p65, and p-IκBα (Figure 6).In addition, the expression of TLR4, p-p65, and p-IκBα in the C5aRA treatment group was higher than that in the LPS + C5aRA group.
The groups showed no difference in the mRNA and protein expression levels for the p65.Nevertheless, the expression trends for the IκBα mRNA and protein differed.The expression of the IκBα mRNA in the control group was lower than in all other groups.However, the expression of the IκBα protein showed no statistically significant difference among the groups.To further validate these results, we used immunofluorescence to detect the nuclear translocation of p-p65.The results showed that bright red fluorescence in the LPS group was mainly expressed in the nucleus, although a small fraction was observable in the cytoplasm.
Compared to the LPS group, the C5aRA treatment group showed significantly reduced expression of red fluorescent cells in the nucleus, as they were mainly in the cytoplasm.In the control group, bright red fluorescence was observed in the cytoplasm but not in the nucleus (Figure 7).

C5aRA affected MAPK signaling pathway after being treated with LPS
We used Western blotting and RT-qPCR analyses to detect the expression of MAPK pathway-related factors.The LPS stimulation group showed significantly upregulated mRNA and protein expression levels for p-JNK and p-c-JUN, and the C5aRA treatment group showed significantly downregulated mRNA and protein expression levels for p-JNK and p-c-JUN, compared with the control (Figure 8).The mRNA and protein expression levels of the p-JNK and p-c-JUN in the C5aRA treatment group were also higher than those in the LPS + C5aRA group.RT-qPCR showed that the expression of JNK mRNA in the control group was the lowest among the groups (P<0.05).However, JNK protein expression showed no difference between the groups, and we found no statistically significant difference in the expression of the c-Jun mRNA or protein between the groups.

Discussion
HGFs are the most abundant resident cells of gingival connective tissue, which can directly provide the signal to mediate host immune responses and recruit inflammatory cells to clear infection in periodontal injury.Inflammatory cytokines can also be secreted from chemotactic immune cells during HGFs immune responses.Thus, HGFs play a key role in periodontitis pathogenesis. 22Therefore, we selected it as the focus of this study.As previously reported, the fibroblast-like cells were successfully obtained from human gingival tissues using the tissue block method, which is simple, fast, reproducible, and maintains cell viability and function. 23Our results agree with previous studies which reported the typical fibroblastlike morphology of cells isolated from human gingival tissues. 24e main skeletal protein of keratinocytes is Keratin, which is mainly present in epithelial cells.Its main function is to maintain epithelial integrity and continuity.Vimentin is an intermediate filament protein mainly present in the cytoskeleton of mesenchymal cells, and FSP-1 (also known as S100A-4) is a member of the calbindin S100 family, which plays an important role in cell fibrosis, cell proliferation, and motility, and is also commonly used as fibroblast markers.We identified HGFs by detecting the positive expression of vimentin and FSP-1 and the negative expression of keratin using immunofluorescence.The results showed that the cultured cells were from mesodermal mesenchymal tissues and that they exhibited fibroblast characteristics.Combined with the sampling site and histological characteristics, we confirmed that the cells obtained and cultured in our study were human gingival fibroblasts.Gingival tissue also has a resident stem cell population derived from mesenchyme.However, we did not specifically study the ratio of fibroblasts to stem cells in our experiments.On the one hand, the number of stem cells is very low under normal circumstances.
On the other hand, as Denu et al. said, fibroblasts and mesenchymal stromal/stem cells are phenotypically indistinguishable and have almost the same immune regulatory properties. 25Therefore, even if fibroblasts and stem cells were not isolated separately, it would not affect our experimental results.
The complement system is an important part of the immune system and the first line of defense against pathogens and stressed host cells.Complement C5a, the most potent anaphylatoxin, exerts its main proinflammatory activity by interacting with its specific receptor C5aR and becomes the main factor triggering the inflammatory response in various diseases. 26A previous report showed that the complement C5a is an important factor in periodontal disease and can cause inflammation and tissue damage.Even if the dentist effectively removes plaque microorganisms, it is difficult to completely alter the periodontal immune microenvironment.High expression levels of C5a activate the immune process, resulting in the destruction of periodontal tissue, which may be one of the reasons for highly recurrent periodontitis. 16Moreover, the destructive influences of the inflammatory factors IL-6, IL-1β, and TNF-α on periodontal tissue during periodontitis have been well-established in previous studies. 27Our experiment evaluated the activation of the C5a-C5aR signaling axis by analyzing the variations of C5aR expression levels.In addition, many studies have used LPS to establish an in vitro periodontitis cell model.As a potent activator of inflammation, LPS leads to the over-release of inflammatory cytokines, such as IL-6, IL-1β, and TNF-α. 28CCK8 was used to determine the optimal concentration and time for LPS administration to generate periodontitis cell models in vitro.Based on the differences in the mRNA expression levels of C5aR, IL-6, IL-1β, and TNF-α , the 1 μg/mL LPS for 48 h was the optimal stimulation condition (supplementary data S1 and S2).These results also showed that the group of 0.1 μg/mL LPS had better cell viability than the control group.The results indicate that HGFs can promote cell proliferation when stimulated by a very low concentration of LPS, which may be related to the high recovery ability of the gingival tissue itself.
However, not all immune responses are destructive, and complement is also crucial for the defense against infection.Therefore, we chose a C5aR antagonist

TLR4 recognizes bacterial lipopolysaccharide (LPS)
and participates in and mediates the activation of the NF-κB signaling pathway. 29The NF-κB signaling pathway exists in almost all cell types and can be rapidly activated when an organism is subjected to harmful internal and external stimuli, and this helps to regulate many life processes and diseases in cells and organisms.The binding of NF-κB to its inhibitor IκB proteins exists in the cytoplasm in the resting state.Once activated, IκB is phosphorylated by proteases, and free p-p65 is transported into the nucleus to mediate the transcription of inflammatory genes.Growing studies suggest that TLR4-regulated NF-κB signaling is critical to inflammatory responses.
For example, prediabetes-enhanced periodontal inflammation in rats can inversely activate TLR4 and increase the accumulation of p-p65 in the nucleus, while baicalin inhibits experimental rat teeth by downregulating TLR4 expression and inhibiting the nuclear translocation of p-p65 to inhibit the development of periarthritis.[32] Agreeing with previous findings, our results showed that LPS stimulation upregulated the expression of TLR4, p-p65, and p-IκBα in HGFs and increased the nuclear translocation of p-p65. 9These studies showed that LPS can activate TLR4, induce the phosphorylation of p65 and IκBα proteins.In contrast, the C5aRA treatment reversed the increased expression of TLR4, p-p65, and p-IκBα and inhibited the nuclear translocation of p-p65.Taken together, this shows that C5aR antagonists inhibit LPS recognition by TLR4 and inactivated the NF-κB pathway.
After TLR4 recognizes LPS, it triggers an intercellular signaling cascade, which activates the downstream NF-κB pathway, as well as MAPK pathway. 33,34JUN NH2-terminal kinases (JNKs) are a subfamily of MAPKs, and previous studies showed that JNK activation is related to the phosphorylation of the Unusually, results displayed that the mRNA expression of IκBα and JNK in the control group was significantly lower than those in the other groups, whereas the total expression for the IκBα and JNK proteins did not change significantly in each group.On the one hand, this may be because after the cells were stimulated, the gene expression was instantaneously high, which may be reduced after the stress.On the other hand, protein synthesis may also be complex, and the processes of mRNA transcription, translation, and modification that enable protein expression, are affected by many factors. 38However, our follow-up period was relatively short, requiring further research to confirm these findings.
Our study showed some interesting results.The C5aRA group not only upregulated the expression of C5aR and IL-6, IL-1β, and TNF-α but also activated NF-κB and MAPK signaling pathways when compared with the LPS + C5aRA group.This may be due to an imbalance in the original complement system caused by the C5aRA treatment of the HGFs.However, the specific reasons for this require further investigation.
Previous research has confirmed that the MAPK signaling pathway is closely associated with regulating the AP-1 pathway. 33,34Furthermore, studies also showed that although NF-κB and AP-1 transcription factors are mediated by various mechanisms, the fact that activation of the inflammatory cytokines or MAPK signaling pathways is usually accompanied by nuclear translocation of NF-κB, suggests that the transcription factor AP-1 and NF-κB signaling pathway often have a synergistic effect. 39Furthermore, studies have speculated that a clue to the interaction between AP-1 and NF-κB activation pathways is the discovery that the activation of the MAPK pathway leads to the activation of the JNK and IκB kinase complexes. 40Our experimental results confirm this hypothesis.After HGFs were stimulated by LPS, both the NF-κB and MAPK signaling pathways were activated, and the AP-1 signaling pathway was activated by the expression of p-c-JUN, which in turn led to the secretion of IL-1β, IL-6, and TNF-α.We speculate that this may be because many pathogenic stimuli that trigger the activation of the NF-κB pathway also induce cascades such as the MAPK signaling pathway, and these signaling pathways cooperate, resulting in the phosphorylation of the transcription factor AP-1, which promotes the release of inflammatory factors.

Conclusions
In short, our findings suggest that while C5aR antagonists inhibit the binding of C5a and C5aR, they also inhibit TLR4-mediated activation of the NF-κB/ MAPK signaling pathway, thus inhibiting the expression of IL-6, IL-1β, and TNF-α.C5aR antagonists may also regulate the balance of the immune system by eliminating the synergistic effect of C5a and TLR4 on immune inflammation in periodontal tissues, ultimately inhibiting inflammation.The proposed mechanism illustration was presented in Supplementary Figure .Additionally, whether the C5aR antagonist (W54011) promotes a protective immune response needs further study.Thus, the results not only highlight the vital role of the complement system in the development of periodontitis but also provide new evidence for the potential value of a C5aR antagonist (W54011) as a novel therapeutic approach for complement-dependent inflammatory diseases.

Introduction
Periodontal disease begins as a bacterial infection.
) and C5aRA (PMX205) are cyclic hexapeptides, which are non-competitive inhibitors of C5aR.14 PMX53 and PMX205 are widely used as non-peptide antagonists.Studies showed that they could significantly inhibit C5a-mediated inflammatory diseases, although the oral bioavailability of PMX205 and PMX53 is only 23% and 9%.[15][16][17]W54011 is an orally active non-peptide C5a receptor antagonist (C5aRA) developed by Mitsubishi Pharmaceutical.It can inhibit C5a activation by inhibiting the binding of C5a to its receptor C5aR.W-54011 is a competitive antagonist with stronger affinity than non-competitive antagonists and high oral bioavailability and is known as the most effective small C5aRA molecule.18Previous research showed that C5aRA (W54011) can reduce kidney damage by inhibiting the MAPK signaling pathway,19    and it can also be used as a novel therapeutic to improve sleep deprivation-mediated spatial memory impairment by inhibiting neuroinflammation and adult neurogenesis decline in the hippocampus. 20W54011 can also protect lung cells and tissues from LPS-induced damage by alleviating inflammation and pyroptosis.21These studies suggest that W54011 may C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways help to treat inflammatory diseases mediated by C5a.However, whether C5aRA (W54011) can inhibit the inflammatory response of gingival fibroblasts to treat periodontitis has not yet been reported.Therefore, we used LPS as an inflammatory model to induce gingival fibroblasts and aimed to ensure the inhibition of C5aRA (W54011) on the C5a-C5aR axis, which subsequently inhibits the expression of inflammatory cytokines in LPS-stimulated HGFs.Furthermore, we also aimed to clarify the antiinflammatory effect and mechanism of C5aRA by verifying the involvement of the classical inflammatory response signaling pathways NF-κB and MAPK.

Figure 1 -
Figure 1-Primer sequences used for RT-PCR and RT-qPCR supernatant was subjected to the Pierce™ BCA Protein Assay kit (Beyotime, China) for protein concentration.A sample of 10 μg was added to each lane of the gel separately.SDS-PAGE (10%) was performed for C5aR, p-IκBα , IκBα , p-p65, p65, c-JUN, p-c-JUN, JNK, p-JNK, TLR4, and actin antibodies, and 15% SDS-PAGE was performed for IL-1β, IL-6, and TNF-α antibodies.Separated proteins were transferred onto PVDF membranes (Bio-Rad Laboratories, Inc.).The membranes were blocked with 5% skimmed milk at Data were analyzed for normality distribution using the Shapiro-Wilk test.Comparisons between the groups were assessed using one-way ANOVA, followed by Bonferroni multiple comparisons using GraphPad 8.

Figure 3 -
Figure 3-Identification of the second passage cells from HGFs with immunofluorescent staining.(A-C)The green positive expression of FSP-1 in the cytoplasm of HGFs.(D-F)Keratin is unstained in the cytoplasm.(G-I)The positive staining of vimentin in the cytoplasm of HGFs was red fluorescence.The positive staining of nucleus of HGFs was blue fluorescence.Scale bar =100μm.Fluorescence microscope × 200

Figure 4 -
Figure 4-The content of C5a in the cell supernatant of the different group was measured by the ELISA assay.Data represent the mean ± SEM of three independent experiments.+P < 0.05 vs. the control group.*P < 0.05 vs. the LPS+C5aRA group

Figure 7 -
Figure 7-The effects of C5aRA on p-p65 translocation into the nucleus were used to detect by immunofluorescence staining.(A-C)LPS+C5aRA group.(D-F)The control group.(G-I)LPS group.The blue staining represented the nucleus; the green staining was p-p65.Scale bar = 50μm.Fluorescence microscope × 400

Figure 8 -
Figure 8-Effects of C5aRA on MAPK signal pathway activation in LPS-stimulated HGFs.(A)Effects of C5aRA on mRNA levels of JNK, p-JNK, c-JUN, and p-c-JUN in LPS-stimulated HGFs.(B) Effects of C5aRA on protein levels of JNK, p-JNK, c-JUN, and p-c-JUN in LPSstimulated HGFs.Data represent the mean ± SEM. of three independent experiments.+P<0.05 vs. the control group.*P<0.05 vs. the LPS+C5aRA group

(
W54011) to target periodontitis, which can not only specifically inhibit the biological activity of C5aR but can Y CHEN, Y LIU, H LI, R HUNA, X TAN, N LI, Y ZHANG, X JIAO, M LIU also gain therapeutic benefits without compromising the protective immune response.To better study the mechanism by which C5aRA inhibits inflammation, we screened the concentrations and durations of action for C5aRA (supplementary data S1 and S3).The CCK8 assay and RT-PCR determined that the treatment with 1 μg/mL C5aRA for 48 h unaffected cell activity but significantly reduced the mRNA expression of C5aR, IL-6, IL-1β, and TNF-α .The expression results of C5aR and inflammatory factors detected by RT-qPCR and Western blot analysis indicate that LPS can activate the complement system in HGFs and promote the inflammatory response.The ELISA result of C5a also showed the effectiveness of activation of the complement system stimulated by LPS.Therefore, we suggest that LPS can be considered a typical "in vitro model" of gingival fibroblast inflammation.Additionally, after LPS-stimulated HGFs were treated with C5aRA, the expression of C5aR, IL-6, IL-1β, and TNF-α significantly decreased.However, there was no significant change in the expression of C5a.This indicates that C5aRA did not affect C5a expression.More importantly, C5aRA can effectively inhibit C5aR expression, thus reducing the binding efficiency of C5a to C5aR and inhibiting the activation of the complement system to control inflammation.
JNK-dependent transcription factor c-JUN (a subunit of AP-1).Phosphorylation of JNK activates the MAPK signaling pathway, which partially activates the AP-1 transcription factor by initiating the phosphorylation of c-JUN, thus promoting the secretion of inflammatory factors. 35Such process has also been confirmed by many studies; for example, tormentic acid inhibits LPS-stimulated inflammation by preventing the activation of TLR4-mediated NF-κB and p38 MAPK pathways; prolyl hydroxylases positively regulate the inflammatory effects of LPS-induced HGFs via TLR4-mediated NF-κB and MAPK pathways; 36 and sulforaphane may inhibit the inflammatory effects of LPS-activated microglia by inhibiting the JNK/AP-1/ NF-κB signaling pathway. 37To further investigate the regulatory mechanism of C5aRA, we first stimulated HGFs with LPS.RT-qPCR and Western blotting results showed that the expression of p-JNK and p-c-JUN significantly increased.The expression levels of p-JNK and p-c-JUN were significantly downregulated after the C5aRA treatment, indicating that C5aRA significantly prevented the phosphorylation of JNK and c-JUN.Our results show that C5aRA blocks the MAPK signaling pathway and the activation of its downstream transcription factor AP-1.